GlassScriptPhysician profile
Anthony T Bernens
NPI 1215983440
$6,323.59
in general payments reported to CMS, 2019-2025
39 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $971 · 2020: $1,450 · 2021: $1,746 · 2022: $742 · 2023: $747 · 2024: $380 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,415.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,107.80 | 2019-2024 | Xarelto |
| Pfizer INC. | $746.67 | 2019-2023 | |
| Abbvie INC. | $615.06 | 2021-2025 | Ubrelvy, Linzess, Viberzi |
| Amgen INC. | $462.06 | 2019-2025 | Otezla, Repatha, Evenity |
| Allergan, INC. | $419.34 | 2019-2020 | |
| Glaxosmithkline, LLC. | $292.90 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Biohaven Pharmaceuticals, INC. | $257.61 | 2020-2021 | |
| Daiichi Sankyo INC. | $257.02 | 2019-2024 | Injectafer |
| E.R. Squibb & Sons, L.L.C. | $185.95 | 2019-2023 | Eliquis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $180.30 | 2019-2024 | Xifaxan, Trulance |
| Lilly USA, LLC | $169.40 | 2019-2023 | Synjardy, Emgality, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.98 | 2019-2022 | |
| Exact Sciences Corporation | $119.76 | 2024-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $119.63 | 2022 | |
| Arbor Pharmaceuticals, INC. | $111.75 | 2019-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Bernens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.